<?xml version="1.0"?> <rss version='2.0' xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Official Newsfeed]]></title><description><![CDATA[]]></description><link>https://app.meltwater.com</link><atom:link href="https://app.meltwater.com/gyda/outputs/58479da599563cf7c9a8e96c/rendering?apiKey=583efa46479641bbce41a719&amp;type=rss" rel="self" type="application/rss+xml" /><item><title><![CDATA[Sanofi Genzyme wins approval for breakthrough drug to treat severe form of eczema]]></title><link>https://www.bostonglobe.com/business/2017/03/28/sanofi-genzyme-wins-approval-for-breakthrough-drug-treat-severe-form-eczema/8hJPRKvBtn8SoJ2IaJjkpK/story.html</link><description><![CDATA[The Food and Drug Administration on Tuesday approved a drug made by Sanofi Genzyme to treat a rare and debilitating form of eczema. The]]></description><guid>https://www.bostonglobe.com/business/2017/03/28/sanofi-genzyme-wins-approval-for-breakthrough-drug-treat-severe-form-eczema/8hJPRKvBtn8SoJ2IaJjkpK/story.html?docId=g446TfMOXTfBy7ejTUl82pvbAzw</guid><pubDate>Tue, 28 Mar 2017 18:26:42 +0200</pubDate><source url="https://www.bostonglobe.com/">The Boston Globe</source><media:thumbnail url="http://www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/03/23/BostonGlobe.com/Business/Images/05071405.jpg"/></item><item><title><![CDATA[Lawmakers in deep-red Kansas just voted to expand Medicaid]]></title><link>https://www.washingtonpost.com/news/post-nation/wp/2017/03/28/lawmakers-in-deep-red-kansas-just-voted-to-expand-medicaid/</link><description><![CDATA[it was meant to replace, known as Obamacare.

The Kansas state Senate voted 25 to 14 Tuesday to expand Medicaid — the state-federal program]]></description><guid>https://www.washingtonpost.com/news/post-nation/wp/2017/03/28/lawmakers-in-deep-red-kansas-just-voted-to-expand-medicaid/?docId=64IQVI2L_O-XrUYf3tcC8xn82VU</guid><pubDate>Tue, 28 Mar 2017 18:11:18 +0200</pubDate><source url="https://www.washingtonpost.com/">The Washington Post</source><media:thumbnail url="https://img.washingtonpost.com/rf/image_1484w/2010-2019/WashingtonPost/2017/03/17/National-Politics/Images/AFP_M24QUb.jpg"/></item><item><title><![CDATA[Chris Berka’s Lifelong Quest To Make Consciousness Visible]]></title><link>https://www.fastcompany.com/3068983/chris-berkas-lifelong-quest-to-make-consciousness-visible</link><description><![CDATA[are now the company’s fastest growing segment. They began working with Biogen three years ago, looking for EEG markers in Alzheimer’s, then]]></description><guid>https://www.fastcompany.com/3068983/chris-berkas-lifelong-quest-to-make-consciousness-visible?docId=SYZj57-NT8BTqUGwDKcJeZLI_wM</guid><pubDate>Tue, 28 Mar 2017 18:00:00 +0200</pubDate><source url="https://www.fastcompany.com/">Fast Company</source><media:thumbnail url="https://assets.fastcompany.com/image/upload/w_1280,f_auto,q_60,fl_lossy/fc/3068983-poster-p-1-chris-berka-and-brain-states.jpg"/></item><item><title><![CDATA[Could Sandoz have stalled Mylan's generic Advair? Maybe so, analyst says, citing FDA post]]></title><link>http://www.fiercepharma.com/pharma/could-sandoz-have-stalled-mylan-s-generic-advair-try-maybe-so-analyst-says</link><description><![CDATA[- GlaxoSmithKline - Novartis

And the way Evercore ISI analyst Umer Raffat sees it, that response may be a bad sign for Mylan.

“Had FDA]]></description><guid>http://www.fiercepharma.com/pharma/could-sandoz-have-stalled-mylan-s-generic-advair-try-maybe-so-analyst-says?docId=x5AqPNKRxQKwpbj5hjFEakKiuKA</guid><pubDate>Tue, 28 Mar 2017 17:08:34 +0200</pubDate><source url="http://www.fiercepharma.com/">FiercePharma</source><media:thumbnail url="http://qtxasset.com/2017-03/fda1_1.jpg"/></item><item><title><![CDATA[Hope for devastating child disease comes at a cost: $750,000 a year]]></title><link>https://www.bostonglobe.com/business/2017/03/27/spinraza/QnBmQrcmLLfUwvJunn0P8K/story.html</link><description><![CDATA[carriers — are covering Spinraza for all patients. Biogen chief executive Michel Vounatsos told a health care conference earlier this month]]></description><guid>https://www.bostonglobe.com/business/2017/03/27/spinraza/QnBmQrcmLLfUwvJunn0P8K/story.html?docId=g0Tt46O_sNDIFnzkPeNyZCQIPl4</guid><pubDate>Tue, 28 Mar 2017 05:26:15 +0200</pubDate><source url="https://www.bostonglobe.com/">The Boston Globe</source><media:thumbnail url="http://www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/03/22/BostonGlobe.com/Business/Images/blanding03211723spinraza5biz.jpg"/></item></channel></rss>